Mirtazapine, a tetracyclic antidepressant initially developed for human use, has been widely used in feline medicine due to its anxiolytic, antiemetic, and appetite stimulant properties. Some psychotropic medications have been shown to modulate immune activation, but the effects of mirtazapine on the cat’s immune system remain unclear. This study aimed to evaluate the in vitro effects of mirtazapine on gene expression of the proinflammatory cytokines TNF-α and IL-6 in peripheral blood mononuclear cells (PBMC) from healthy domestic cats. TNF-α and IL-6 are involved in the pathogenesis of inflammatory and infectious diseases affecting felines. For this purpose, PBMC from cats were treated overnight with 50 μM of mirtazapine, and the expression of these cytokines was analyzed by real-time PCR. There was a significant reduction in the expression of TNF-α and IL-6 in the treated cells compared to the control group, indicating an anti-inflammatory effect of mirtazapine. The anti-inflammatory effects of mirtazapine may represent a novel therapeutic option for cats with inflammatory conditions.